Annexin-A1: Therapeutic potential in microvascular disease
Annexin-A1 (ANXA1) was first discovered in the early 1980's as a protein, which mediates (some of the) anti-inflammatory effects of glucocorticoids. Subsequently, the role of ANXA1 in inflammation has been extensively studied. The biology of ANXA1 is complex and it has many different roles in b...
Auteurs principaux: | Purvis, G, Solito, E, Thiemermann, C |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Frontiers Media
2019
|
Documents similaires
-
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
par: Purvis, G, et autres
Publié: (2017) -
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
par: Zhibin Yan, et autres
Publié: (2022-11-01) -
Annexin 1 and the regulation of endocrine function.
par: John, C, et autres
Publié: (2004) -
Annexin A1 in the brain--undiscovered roles?
par: Solito, E, et autres
Publié: (2008) -
Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.
par: Buckingham, J, et autres
Publié: (2006)